SUMMARY We report on a case of adriamycin cardiotoxicity occurring In a five-year-old boy treated for rhabdomyosarcoma. In addition to the usual features of myofibrillary degeneration associated with adriamycin, extreme endocaridal fibrosis and mural thrombosis affecting the apical segments of both ventricles but particularly the left ventricle was seen at necropsy. The changes resembled classical endomyocardial fibrosis.
Adriamycin is an antineoplastic drug and is effective against a variety of solid tumours. Several side effects including alopecia, stomatitis, and bone marrow suppression have been reported.' However, the major side effect which has restricted its use is that of cardiotoxicity.2 3 We describe a case of adriamycin cardiotoxicity showingextremely unusual, and apparently previously unreported, gross morphological changes, characterised by extreme endocardial and myocardial fibrosis resulting in a lesion that resembled endomyocardial fibrosis.4
Case report A five-year-old boy was admitted for investigation of abdominal pain, fever and dysuria which had been present for four weeks before admission. Physical examination showed a rounded, tender, firm mass approximately 8 cm in diameter, located in the right lower quadrant of the abdomen. No other abnormality was noted on physical examination and in particular, there were neither heart murmurs nor any evidence of heart disease. An intravenous pyelogram confirmed the presence of a mass on the pelvic brim on the right side, with associated right hydroureter and hydronephrosis. A chest x-ray examination showed no abnormality. Laboratory investigations did not further a diagnosis. At laparotomy a firm, fleshy tumour mass adherent to the right pelvic wall and urinary bladder was identified. No metastases were seen in the field of operation, nor were any palpable elsewhere in the abdomen. A partial resection was performed, and histological examinaAccepted for publication 5 (Fig. 1) . The involvement of the chordae tendinae was associated with moderate dilatation of the mitral valve (17 cm). These features were reminiscent of endomyocardial fibrosis.
Histological examination of multiple blocks from several areas of the myocardium showed similar features. In all areas there was extensive interstitial fibrosis, with decreased numbers of muscle fibres. Many of the surviving fibres showed vacuolation, variation of nuclear size and shape and blurring of the cross striations (Fig. 2) . The thickened, fibrotic areas of endocardium showed the presence of organising, lamellar, thrombus. In the deeper strata, occasional bundles of degenerated myocardial fibres were present. The fibrous tissue of the organising lamellar thrombus merged with the areas of interstitial fibrosis (Fig. 3) . No inflammatory infiltrate was noted.
ULTRASTRUCTURAL FINDINGS
At the time of necropsy, selected areas of myocardium away from the fibrotic areas had been fixed in 2 % phosphate-buffered glutaraldehyde, and epon embedded sections were stained with uranyl acetate and lead citrate. The sections were studied using a Philips 300 electron microscope. Examination of these sections showed extensive degeneration and loss of myofibrils, swelling of mitochondria, absence of glycogen granules and dense intramitochondrial deposits. In addition there were multiple areas of fraying of the Z Bands and extension of Z Band substance into the sarcoplasm (Fig. 4) .
Discussion
The microscopic and ultrastructural changes de- scribed in this case are characteristic of the cardiotoxicity associated with adriamycin, and have been described in detail in several reviews.5-10 These changes occur infrequently when total cumulative dosages are less than 550 mg/M2, although mediastinal irradiation, dactinomycin and cyclophosphamide treatment have been shown to facilitate its development at lower total dosages of adriamycin. Our patient was treated with dactinomycin and cyclophosphamide, but it is worth emphasising that the mediastinum was not irradiated, and the total cumulative dose of adriamycin was relatively low.
Endocardial fibrosis and mural thrombi are reported in cases of adriamycin cardiotoxicity but usually they are relatively minor features.'0 In our patient, the endomyocardial fibrotic change was the most striking anomaly and since the chordae tendinae Fitter, deSa, Pal of the mitral valve were involved, it would have accentuated the effects that any myocardial damage might have had.
Similar morphological changes to those seen in our patient have been described in another patient who was treated with daunorubicin (a close analogue of adriamycin)."1 Although the conditions in our patient, and the earlier patient" resemble classical African endomyocardial fibrosis, our case lacked the inflammatory infiltrate that is described by some'2 13 into the pathological mechanisms involved in classical endomyocardial fibrosis.
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